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The presence of the parathyroid hormones in vertebrates, including PTH, PTH-related pep-
tide (PTHrP), and tuberoinfundibular peptide of 39 residues (TIP39), has been proposed to
be the result of two rounds of whole genome duplication in the beginning of vertebrate
diversification. Bioinformatics analyses, in particular chromosomal synteny study and the
characterization of the PTH ligands and their receptors from various vertebrate species,
provide evidence that strongly supports this hypothesis. In this mini-review, we summa-
rize recent advances in studies regarding the molecular evolution and physiology of the PTH
ligands and their receptors, with particular focus on non-mammalian vertebrates. In sum-
mary, the PTH family of peptides probably predates early vertebrate evolution, indicating
a more ancient existence as well as a function of these peptides in invertebrates.
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Although the physiological actions of parathyroid hormone family
are well-documented in the literature, review about the molec-
ular evolution of PTH ligands and their receptors are limited.
Therefore, in this article, we reviewed recent studies about the
PTH ligands and their receptors in different vertebrate species.
We believe this mini-review can provide a better overview about
the molecular evolution of this ligand and receptor family in
vertebrate.
PARATHYROID HORMONE FAMILY
The parathyroid hormone peptide subfamily includes PTH, PTH-
related peptide (PTHrP), and tuberoinfundibular peptide of 39
residues (TIP39, also known as PTH2). These hormones are
encoded in separate genes but their mature peptides share sig-
nificant sequence homology within the first 34 amino acids. In
humans, PTH is highly expressed and is secreted by the parathy-
roid gland, but lower levels of its transcript can also be detected in
the hypothalamus, pituitary, and thymus (1–3). PTH is an impor-
tant regulator for body calcium homeostasis. In contrast to PTH,
PTHrP is widely expressed in a broad spectrum of tissues, includ-
ing central nervous system (4). The main function of PTHrP is
the regulation of chondrocyte growth and differentiation in the
growth plates of developing long bones (5). TIP39 shares a rel-
atively lower level of sequence homology with PTH or PTHrP,
but high resolution NMR studies suggest that it has a similar
three-dimensional structure when compared to them (6). TIP39 is
mainly synthesized in two brain regions, the subparafascicular area
of the thalamus and the medial paralemniscal nucleus of the pons
(7). Recent reports suggest that TIP39 is a neuroendocrine hor-
mone that modulates several aspects of the stress response, as well
as controls body temperature (8). In addition to PTH, PTHrP, and
TIP39, there is a newly identified member of the family, PTH-like
peptide (PTH-L),which is only present in non-mammalian species
including Xenopus, teleosts, and chicken. pth-l gene structure is
similar to that of the pth gene, but the mature peptide of PTH-L
shares a higher level of sequence homology to PTHrP (9). The
expression of PTH-L has been investigated in chicken and Xeno-
pus. The peptide was found widely, but differentially expressed in
various tissues of these organisms. Abundant PTH–L transcripts
were detected in cartilage in chicken, and in brain, lung, and bone
in Xenopus laevis (10). Although the physiological role has not yet
been fully established, some reports have suggested that PTH-L in
teleosts (Seabream) and X. laevis is the most potent calciotropic
factor among all PTH peptides (10, 11).
PTH RECEPTOR FAMILY
The importance of the PTH system as a regulator to control blood
calcium levels was recognized early in the 20th century by observ-
ing the correlation between the parathyroid gland and tetany (12,
13). However, understanding of the physiological function of PTH
was not substantially developed until the discovery of the human
PTH1R in 1991 (14). PTH1R is also called the PTH/PTHrP recep-
tor because of its equal binding affinities for both PTH and PTHrP.
Subsequently, PTH2R, with a ligand preference for PTH over
PTHrP, was identified in humans (15). However, further inves-
tigations suggested that TIP39 is the native ligand of PTH2R
because of the robust activation of human PTH2R by TIP39 and
the poor activation of rat PTH2R by PTH (16). In the last two
decades, due to the success of different genome projects, paralogs
and orthologs of PTHRs have been identified from various ver-
tebrate species. These studies have also led to the discovery of
an additional member of the receptor family, PTH3R, which is
found only in non-mammalian vertebrates. The ligand specificity
and structure of PTH3R resemble PTH1R more than PTH2R (17–
19). In zebrafish, seabream, and chicken, PTH3R shows a stronger
affinity for PTHrP than do other members of the PTH receptor
family (17, 18, 20).
EVOLUTION OF PTH AND THE PTHR FAMILY
The PTHRs belong to the class B1 G protein-coupled receptors
(GPCRs). It is widely believed that the paralogs of PTHR, pth1r,
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pth2r, and pth3r are evolved after two rounds of whole genome
duplication (2WGD) (17, 21–23). Recent genome synteny com-
parison provided strong evidence to support this hypothesis (22).
From teleosts to humans, PTHRs are found in three conserved
loci. Interestingly, PTH2R and PTH3R are not found in birds and
mammals, respectively. The genes for the PTHR cognate ligands
(pth, pthrp, and tip39) are also located in three conserved loci and
were likely generated through similar WGD events as their recep-
tors. The pth-l gene is found in the fourth locus in chicken, which
shares considerable synteny with the other three conserved loci of
the pth gene family. Specifically in teleost, the third WGD generate
extra copies of pth (pth1 and pth2) and pthrp (pthrpA and pthrpB),
but whether the copies share the synteny with PTH gene family
remains to be investigated (11, 24).
The elephant shark was diverged at the time point just after
the vertebrate 2WGD; therefore, its primitive genome provides
insight into the evolution of the PTH and PTHR family (25, 26).
Consistent with the “4:1 rule” (27, 28), except for the loss of the
fourth putative PTHR, all the homologs of PTH and the PTHR
genes could be identified in elephant shark (hereafter abbreviated
to “e”) (17, 29). PTH, PTHrP, and putative ePTH-L (designated as
PTH2 in the references) have already been cloned, while a putative
tip39 gene was identified in the genome database (17, 29). Even
though ePTH2 is phylogenetically grouped with other PTH-Ls, the
identity of ePTH2 as an ortholog to fish PTH-L was questioned
because the gene structure of ePTH2 is different from teleost pth-
l, but resembles other pth genes. Elephant shark pth2 has its first
intron before the KR cleavage site; whereas teleost pth-l genes do
not contain this cleavage site, and instead have the first intron
before the SRR motif (29). More importantly, ePTH2 is unable to
stimulate cAMP production in PTH1R expressing cells, but teleost
PTH-L appears to be a potent factor (29).
Regarding the evolution of PTH and the PTHR family in early
vertebrates, hypotheses have been proposed largely based on bioin-
formatics data (17, 21,22,30). In lamprey, the distinct phylogenetic
positions of the two deduced PTH-like receptors and hormones,
suggested a possible scenario of PTHR/PTH evolution before
2WGD (17). PTH1R-like and PTH2R-like genes were produced
after the first round of WGD. Then, after the divergence of lam-
prey, the second round of WGD resulted in only PTH3R due to the
lost of the fourth receptor in the PTH2R lineage. For the ligands,
PTHrP and TIP39 were proposed to be the pioneers of the PTH
family, since they are present in agnathan genomes (18).
In invertebrates, PTHR-like genes are found in the genomes
of protostomians, cephalochordates, and urochordates. This indi-
cates the ancestral PTHR was evolved before the deuterostome-
protostome split (21, 22, 30). Regarding the ligands, a recent
bioinformatics approach has identified PTH-like peptides in tuni-
cates and amphioxi (31). Even though the invertebrate peptides
share relatively low homology to the vertebrate PTH family, these
observations indicate that the PTH family of peptides already
existed in cephalochordates.
EVOLUTIONARY CHANGES IN GENE STRUCTURES OF THE
PTH FAMILY
After divergence from their last common ancestor, PTHrP exhib-
ited more changes in gene structure than PTH. The classic gene
structure of pth contains three exons with the prepro-peptide are
encoded in the last two exons. This gene structure is conserved
from elephant shark to human (10, 24, 29). However, the pthrp
gene structure differs through vertebrates by the introduction of
exons upstream and/or downstream of the mature peptide cod-
ing regions, and presence of splicing variants in Xenopus, chicken,
and human (10, 32). In addition, unlike PTH and PTH-L, their
precursor proteins that lead to single mature peptide, posttrans-
lational processing of mammalian prepro-PTHrP can give rise to
three mature peptides: PTHrP, middle region, and osteostatin (33,
34). The increase of pthrp gene structure complexity during ver-
tebrate evolution may reflect changes in the physiological roles of
this peptide, such as adaptation to the terrestrial environment in
tetrapods (9, 35). The new member of the PTH family, PTH-L
in non-mammalian vertebrates, was considered as an intermedi-
ate between PTH and PTHrP due to its independent phylogenetic
position to both PTH and PTHrP (10, 11). Moreover, although the
gene structure of PTH-L resembles that of PTH in fugu, chicken,
and Xenopus, alternative transcripts were reported for Xenopus
and chicken PTH-L. In addition, all investigated PTH-L peptides
contain the “MHD” motif, which is the characteristic of teleost
PTHrP (9–11). In elephant shark, all the PTH peptides possess
the “MHD” motif (29), suggesting that this motif is present in the
common ancestor of PTH peptides and was lost during evolution
in some vertebrates. Among all PTH family members, the unique
properties of TIP39 are shown by its distant position from other
members in phylogenetic analysis, and by the lack of “MHD” or
any similar motif (36, 37). The gene structure of TIP39 is highly
conserved from mammals to teleosts, and like that of PTH, has
three exons (37). The uniqueness of TIP39 could be a result of its
earlier divergence from other members of the PTH family.
LIGAND BINDING OF PTHRs IN VERTEBRATES
Significant levels of sequence homology are found in the first 34
amino acids of mature PTHrP, PTH, and PTH-L peptides. This
region is important for receptor binding and receptor activation
(9, 10, 16). In mammals, it has been shown that activation of
PTH1R by PTH(1–34) and PTHrP(1–34) are comparable to that
by the corresponding full length peptides (38, 39). The biological
activity of PTH(1–34) was indicated by administration of PTH(1–34)
to patients with osteoporosis, which resulted in enhanced bone
development (40, 41). PTH(15–34) are required for high affin-
ity binding through interaction with the extracellular N-terminal
domain of the receptor (42, 43). Such functional division within
PTH in receptor interaction is also likely for PTHrP and TIP39,
as well as for interaction of PTH2R with PTH-like peptides, as
shown by studies of ligand variants and chimeric receptors (44–
47). Functional testing using truncated PTHrP(2–34, 3–34, and 7–34)
indicated that these peptides were unable to trigger cAMP syn-
thesis but could stimulate the PLC pathway. In summary, the
first few residues are essential to the cAMP pathway but not for
receptor binding (48). These properties of truncated PTH(7–34)
and PTHrP(7–36) were utilized for developing antagonists of
PTH1R (47).
Table 1 summarizes the ligand specificity of the PTHR fam-
ily in various species. Human (hu) PTH1R can be activated by
PTH and PTHrP with indistinguishable potency in downstream
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Table 1 | Ligand specificity of PTHR family.
Receptor Species Assay Ligand specificity Reference
PTH1R Human cAMP hPTHrP≈hPTH≈ zPTH1≈ zPTH2> fPTHrP, no response to TIP39 (14, 24)
PLC hPTHrP≈hPTH (19)
ERK1/2 hPTHrP≈hPTH (51)
IP1 hPTHrP≈hPTH (51)
Bindingc hPTHrP≈hPTH (52)
Mouse cAMP hPTHrP≈hPTH, no response to TIP39 (50)
Rat cAMP rPTHrP≈ rPTH, no response to TIP39 (16)
Chicken cAMP cPTHrP≈hPTH> cPTH-L> cPTH (17)
PLC cPTHrP, slight stimulation by cPTH-L and no response to and cPTH (17)
Zebrafish cAMP hPTH≈hPTHrP≈ fPTHrPA≈ zPTH1> zPTH2 (18, 24)
PLC hPTHrP≈hPTH (18)
Seabreama cAMP fPTH-L≈ fPTHrPA>hPTH≈bPTH, low respond to hPTHrP, no response to fPTH, and fPTHrPb (11)
PLC fPTHrPA≈hPTHrP≈hPTH≈ fPTH-L≈ fPTHA≈ fPTHB, no response to fPTHrPB and bPTH (11)
PTH2R Human cAMP hTIP39≈ rTIP39≈ rPTH>hPTH (53, 54)
PLC hTIP39≈ rTIP39> rPTH, no response to hPTH (53)
Rat cAMP hTIP39> rPTH (16)
Zebrafish cAMP hTIP39≈ zTIP39>hPTH (36)
(SV) cAMP zTIP39>hTIP39 (36)
PTH3R Chicken cAMP cPTHr> cPTH, low response to cPTH-L (17)
Zebrafish cAMP hPTHrP≈ fPTHrPA≈ zPTH1> zPTH2>hPTH (18, 24)
PLC no response to hPTHrP and hPTH (18)
Seabreamb cAMP fPTHrP, no response to hPTHrP and hPTH (20)
PLC no response to fPTHrP (20)
aScale.
bEnterocyte.
cExtra-cellular domain.
SV, splice variant; h, human; r, rat; z, zebrafish; f, fugu; c, chicken; x, Xenopus.
signaling pathways, including cAMP, phospholipase C (PLC), and
ERK1/2 (49). No activity has been detected for TIP39 in any mam-
malian PTH1R. It is interesting to note that zebrafish (zf) PTH is
able to activate human PTH1R with similar potency to huPTH
(24). This indicates the overall structures of the peptides and the
receptor binding pockets are highly conserved from mammals to
teleosts. Similar ligand specificity is observed in rodents (16, 50)
and teleosts (18, 24). In teleosts, fugu (fu) PTHrPA, huPTHrP, and
zfPTH exhibit similar efficacies for cAMP activation in zfPTH1R.
The only exceptional case is chicken: cPTH1R can be activated by
chicken (c) PTHrP as well as by huPTH with similar potency, but
to a lower extent by cPTH and cPTH-L (17, 18, 24).
Regarding PTH2R, TIP39 was shown to be the native ligand
of PTH2R in mammals and zebrafish (16, 36, 53, 54). huPTH2R
responded similarly to TIP39 and PTH in cAMP activation, but
PTHs were less effective in PLC activation (53). As was the case
for PTH1R, cross-species ligand reactivity is found in zfPTH2R;
huTIP39 has similar potency to the endogenous ligand. In con-
trast, activation of the PLC has not been reported in PTH3R
studies. Treatment of zfPTH3R with huPTHrP or PTH did not
result in PLC stimulation, and consistent results were observed on
treatment of seabream PTH3R with fuPTHrP (18, 20). The lig-
and bias of PTH3R varies in different species. zfPTH3R shows a
preference for fuPTHrP over huPTH, whereas chPTH3R responds
similarly to chicken PTHrP and PTH (17, 18). For seabream
PTH3R, only fuPTHrPA could activate the receptor (20). In sum-
mary, characterization of the PTHR family in various species
shows that their ligand specificity is well conserved. Cross-species
ligand reactivity of PTHRs demonstrates that PTHRs share similar
ligand-receptor binding properties that are conserved throughout
vertebrate evolution.
FUNCTIONAL CHANGES IN THE PTH-PTHR SYSTEM DURING
VERTEBRATE EVOLUTION
Due to the discovery of the relieving effect of PTH and PTHrP
on tetany resulted from parathyroidectomy (12), and also that
PTH and PTHrP are related to humoral hypercalcemic syn-
drome (55–57), initial investigations described the PTH peptides
as endocrine hypercalcemic factors. Later research on PTHrP
and TIP39 explored other possible physiological functions of
these peptides. The vital role of PTHrP in fetal bone develop-
ment was demonstrated in mouse models by deletion of the
PTHrP gene and knockout of PTH1R (58–60). Much work has
been undertaken to determine the wider physiological impor-
tance of PTHrP and has indicated that PTHrP is a multifunctional
paracrine/autocrine factor (61). So far, in placental mammals,
www.frontiersin.org March 2015 | Volume 6 | Article 28 | 3
On et al. Evolution of PTH and PTHR
accumulated knowledge of the widespread PTH/PTHrP-PTH1R
system implicates its pleiotropic functions in regulation of calcium
levels including: (1) the control of the release of calcium from bone
and increase in renal calcium reabsorption; (2) its effect in the
development of bone, cartilage (62–64), pancreas (65, 66), tooth
(67–70), and mammary gland (62); and (3) its function to regulate
placental calcium supply to the fetus (63, 64, 71). In addition, the
C-terminal regions of PTH and PTHrP were postulated to inter-
act with other yet-to-identify receptors, with potential functions
remain to be explored (72–74). On the other hand, the expres-
sion of PTH2R is restricted to the central nervous system, and the
TIP39-PTH2R system is involved in nociceptive signal processing,
regulation of hormonal release from the hypothalamus-pituitary
axis, and modulation of affective behaviors (44). The distinct and
diverse functions of these peptides observed in mammals raised
the question of what are the ancestral functions of the PTH-like
system in non-mammalian vertebrates and even in invertebrates.
Unfortunately, the physiological functions of most PTH peptides
in non-mammalian species have not been investigated in depth,
and functions of these peptides are largely proposed based on the
spatial distribution of their proteins and mRNAs.
The evolution of the parathyroid gland was a key event in the
emergence of the tetrapods. Therefore, the expression of PTH in
the parathyroid gland was originally linked to an evolutionary
concept that the emergence of the PTH-PTHR system was co-
evolved with the adaptive transition from calcium-rich aquatic to
calcium-deficient terrestrial habitats (9, 75). However, the unex-
pected identification of PTH in teleosts completely changed this
view. Now, the cloning of two PTHs from elephant shark con-
firms that PTH-like peptides were present far back in evolution
as cartilaginous fish, suggesting the original role of these pep-
tides is unrelated to bone formation (29). The endocrine action
of PTH released from parathyroid glands in mammals could not
be observed in fish, which have no parathyroid gland. Instead, it
was suggested that PTH is a paracrine factor in non-mammalian
vertebrates such as fish and Xenopus (10). Although the func-
tion of PTH in fish remains poorly described, PTH-L which is
absent from placental mammals, was proposed to mimic the role
of mammalian PTH in fish, since fuPTH-L was found to be a
potent factor causing whole body calcium influx in seabream lar-
vae but no response was detected using fugu PTHA or PTHB (11).
Based on the recent characterization of PTH-L from chicken and
Xenopus, it was hypothesized that there was a functional transi-
tion between PTH-L and PTH during vertebrate evolution. In this
scenario, PTH-L gradually lost its calcitropic activity and eventu-
ally was lost in mammalian genomes, while PTH replaced PTH-L
in mammals to become the main endocrine regulator of calcium
with expression restricted only to the parathyroid gland (10). One
piece of supporting evidence for such a transition is that PTH-L
and PTHrP in chicken andXenopus show overlapping tissue distri-
butions, indicating redundancy. Similarly, immunohistochemistry
in elephant shark showed that the PTH orthologs ,PTH1 and
PTH2, exhibit widespread localization and considerable locational
overlap with PTHrP (29). This implies that PTH-like peptides in
non-mammalian vertebrates and cartilaginous fish may partially
share their physiological role(s) with PTHrP. However, there is a
mismatch between the results of widespread protein detection and
restricted mRNA expression of elephant shark PTH1 and PTH2
(29). Whether this reflects the endocrine action of the two peptides
remains to be determined.
Phylogenetic analysis of two predicted PTH-like in the lamprey
genome, TIP39 and PTHrP, suggests that these are probably the
ancestral members of the PTH peptide family found in vertebrates
(17). In general, the expression of these two peptides appears to be
unchanged in the vertebrate lineage (76). Unfortunately, no exper-
iments have been conducted to determine expression patterns of
lamprey TIP39. Wide tissue expression of PTHrP was observed
in all investigated species to date, and its detection in skin, skele-
tal and, cardiac muscle, and kidney is conserved from lamprey to
human (9, 29, 77, 78). The very similar tissue expression patterns
of TIP39 and PTHrP in zebrafish and lamprey respectively indicate
that TIP39 and PTHrP possess ancestral functions compared with
PTH and PTH-L. In invertebrates, use of heterologous antisera in
immunohistochemistry enabled detection of PTH-like peptides in
snail, cockroach, and amphioxus neural tissue (79). This indicates
that the origin of the PTH family may be far earlier in evolution
than our expectation.
CONCLUSION
Based on bioinformatics, the presence of PTHR dates back to
an ancestor before the deuterostome-protostome split. Although
the true identity of PTH-like peptides in invertebrates requires
clarification, the peptide family likely co-evolved with its cognate
receptors in vertebrates since agnatha. Duplication of this ances-
tral PTHR through 2WGD resulted in the PTHR family found in
modern jawed vertebrate species. Insight from the recent charac-
terization of PTH and the PTHR family from non-mammalian
species, and the discovery of putative PTHR-like and PTH-like,
in a lamprey genome, reveals that the pioneer of the PTH-PTHR
system, and its physiological properties, are likely fundamentally
conserved throughout vertebrate evolution.
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